Evaluation of Baculoviruses as Gene Therapy Vectors for Brain Cancer
Viruses · 2023
DOI: 10.3390/v15030608 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Matías Garcia Fallit und 16 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigaciones Biomédicas (INBIOMED, UBA-CONICET), Facultad de Medicina, Universidad de Buenos Aires, Consejo Nacional de Investigacion…. Hauptthemen laut MEDLINE: Genetic Therapy, Baculoviridae, Genetic Vectors, Brain Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Investigaciones Científicas y Técnicas, Instituto Nacional del Cáncer (Argentina), Agencia Nacional de Promoción Científica y Tecnológica.
Abstract (Originalsprache)
We aimed to assess the potential of baculoviral vectors (BV) for brain cancer gene therapy. We compared them with adenoviral vectors (AdV), which are used in neuro-oncology, but for which there is pre-existing immunity. We constructed BVs and AdVs encoding fluorescent reporter proteins and evaluated their transduction efficiency in glioma cells and astrocytes. Naïve and glioma-bearing mice were intracranially injected with BVs to assess transduction and neuropathology. Transgene expression was also assessed in the brain of BV-preimmunized mice. While the expression of BVs was weaker than AdVs in murine and human glioma cell lines, BV-mediated transgene expression in patient-derived glioma cells was similar to AdV-mediated transduction and showed strong correlation with clathrin expression, a protein that interacts with the baculovirus glycoprotein GP64, mediating BV endocytosis. BVs efficiently transduced normal and neoplastic astrocytes in vivo, without apparent neurotoxicity. BV-mediated transgene expression was stable for at least 21 days in the brain of naïve mice, but it was significantly reduced after 7 days in mice systemically preimmunized with BVs. Our findings indicate that BVs efficiently transduce glioma cells and astrocytes without apparent neurotoxicity. Since humans do not present pre-existing immunity against BVs, these vectors may constitute a valuable tool for the delivery of therapeutic genes into the brain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Instituto de Investigaciones Biomédicas (INBIOMED, UBA-CONICET), Facultad de Medicina, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Ciudad Autónoma de Buenos Aires C1121A6B, A…
- Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires C1428BFA, Argentina.
- Instituto de Biotecnología y Biología Molecular (IBBM, UNLP-CONICET), Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata B1900, Argentina.
- Departamento de Biología Celular e Histología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Ciudad Autónoma de Buenos Aires C1121A6B, Argentina.
- Fundación Para la Lucha Contra las Enfermedades Neurológicas de la Infancia (FLENI), Ciudad Autónoma de Buenos Aires C1121A6B, Argentina.
- Instituto de Ciencia y Tecnología ''Dr. Cesar Milstein", CONICET, Saladillo 2468 (C1440FFX), Ciudad Autónoma de Buenos Aires C1428, Argentina.
ORCID-Profile: Matías L Pidre, Jorge A Peña Agudelo, Melanie Pérez Kuper, Carla M Caruso, Víctor Romanowski, Flavia A Zanetti
Förderung
- Consejo Nacional de Investigaciones Científicas y Técnicas
- Instituto Nacional del Cáncer (Argentina)
- Agencia Nacional de Promoción Científica y Tecnológica
- Fundación Florencio Fiorini
- Consejo Interuniversitario Nacional
Zitieren
APA
Garcia Fallit, M., Pidre, M. L., Asad, A. S., Peña Agudelo, J. A., Vera, M. B., Nicola Candia, A. J., Sagripanti, S. B., Pérez Kuper, M., Amorós Morales, L. C., Marchesini, A., Gonzalez, N., Caruso, C. M., Romanowski, V., Seilicovich, A., Videla-Richardson, G. A., Zanetti, F. A., & Candolfi, M. (2023). Evaluation of Baculoviruses as Gene Therapy Vectors for Brain Cancer. Viruses. https://doi.org/10.3390/v15030608
Vancouver
Garcia Fallit M, Pidre ML, Asad AS, Peña Agudelo JA, Vera MB, Nicola Candia AJ, et al. Evaluation of Baculoviruses as Gene Therapy Vectors for Brain Cancer. Viruses. 2023. doi:10.3390/v15030608
BibTeX
@article{GarciaFallit2023,
author = {Garcia Fallit, Matías and Pidre, Matías L and Asad, Antonela S and Peña Agudelo, Jorge A and Vera, Mariana B and Nicola Candia, Alejandro J and Sagripanti, Sofia B and Pérez Kuper, Melanie and Amorós Morales, Leslie C and Marchesini, Abril and Gonzalez, Nazareno and Caruso, Carla M and Romanowski, Víctor and Seilicovich, Adriana and Videla-Richardson, Guillermo A and Zanetti, Flavia A and Candolfi, Marianela},
title = {Evaluation of Baculoviruses as Gene Therapy Vectors for Brain Cancer},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15030608}
}
EUVIMED